TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Recipharm AB
Closing information (x1000 EUR)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover | 53,506 | 24,237 | 1,102,725 |
Financial expenses | 308,075 | 160,143 | 53,519 |
Earnings before taxes | -1,895 | 7,706 | 49,654 |
EBITDA | -15,852 | -24,311 | 194,341 |
Total assets | 2,651,743 | 1,698,287 | 2,155,696 |
Current assets | 357,185 | 244,110 | 603,298 |
Current liabilities | 190,008 | 162,613 | 334,954 |
Equity capital | 1,616,087 | 690,999 | 732,722 |
- share capital | 4,543 | 4,944 | 3,377 |
Employees (average) | 67 | 64 | 7,857 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency | 60.9% | 40.7% | 34.0% |
Turnover per employee | 799 | 379 | 140 |
Profit as a percentage of turnover | -3.5% | 31.8% | 4.5% |
Return on assets (ROA) | 11.5% | 9.9% | 4.8% |
Current ratio | 188.0% | 150.1% | 180.1% |
Return on equity (ROE) | -0.1% | 1.1% | 6.8% |
Change turnover | 31,232 | -1,058,065 | 359,801 |
Change turnover % | 140% | 48% | |
Chg. No. of employees | 3 | -7,793 | 2,541 |
Chg. No. of employees % | 5% | 48% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.